Management of direct oral anticoagulants in percutaneous coronary and structural interventions
Year: 2026
Type: article
Abstract: The management of direct oral anticoagulants (DOAC) during percutaneous coronary interventions is a common challenge in clinical practice. The periprocedural management remains highly variable and insufficiently evidence based. This review summarizes the pharmacokinetic properties of DOACs, evaluates contemporary guideline recommendations, and examines observational and prospective evidence for interruption versus continuation strategies in coronary and structural interventions. For percutaneous coronary interventions, predominantly via radial-access, observational evidence suggests that uninterrupted DOAC therapy is associated with low rates of bleeding and thromboembolism, questioning the routine practice of pre-procedural interruption in low-risk cases. In contrast, patients undergoing transcatheter structural interventions are older, requiring femoral access, and have a higher baseline bleeding risk. In this setting, recent data do not support routine continuation of anticoagulation. We propose a patient- and procedure-specific approach to DOAC management that prioritizes access site, procedural complexity, and renal function over uniform interruption protocols. There is a need for targeted prospective randomized studies on periprocedural and immediate postprocedural management in these populations.
Source: Kardiologia Polska
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7128828533
FWCI:
Cites:
Cited by:
Related to: